Literature DB >> 7080120

Survival and recurrence following stroke. The Framingham study.

R L Sacco, P A Wolf, W B Kannel, P M McNamara.   

Abstract

Survival and recurrences after stroke were assessed prospectively in a general population sample of 5184 subjects followed biennially for 26 years. Initial strokes occurred in 198 men and 196 women. There were 84 second and 27 third strokes and 223 deaths reported. Thirty day case-fatality rates for initial strokes were: 15% (33/222) for brain infarction, 16% (10/63) for cerebral embolus, 46% (18/39) for subarachnoid hemorrhage, and 82% (14/17) for intracerebral hemorrhage. Cumulative, age-adjusted 5 year survival rates for brain infarction were reduced by pre-stroke cardiac disease (coronary heart disease and/or congestive heart failure) and hypertension prior to initial stroke from .85 to .35 in men and .70 and .56 in women. Hypertension alone reduced survival from .85 to .51 in men, but not in women. Recurrences were primarily of the same type as the initial stroke. Cumulative 5 year recurrence rate for brain infarction was .42 for men, almost double that for women. Rates were reduced by excluding hypertensives and those with combined cardiac comorbidity and hypertension. Thus, risk of death or recurrence after stroke is substantial and profoundly influenced by sex and by cardiac comorbidity and hypertension present prior to the initial event.

Entities:  

Mesh:

Year:  1982        PMID: 7080120     DOI: 10.1161/01.str.13.3.290

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  74 in total

1.  White matter hyperintensity and cognitive functioning in the racial and ethnic minority cohort of the Framingham Heart Study.

Authors:  Karina Stavitsky; Yangchun Du; Daniel Seichepine; Thomas M Laudate; Alexa Beiser; Sudha Seshadri; Charles Decarli; Philip A Wolf; Rhoda Au
Journal:  Neuroepidemiology       Date:  2010-06-15       Impact factor: 3.282

2.  Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.

Authors:  S Warshafsky; D Packard; S J Marks; N Sachdeva; D M Terashita; G Kaufman; K Sang; A J Deluca; S J Peterson; W H Frishman
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

3.  Silent new ischemic lesions after index stroke and the risk of future clinical recurrent stroke.

Authors:  Dong-Wha Kang; Moon-Ku Han; Hye-Jin Kim; Hoyon Sohn; Bum Joon Kim; Sun U Kwon; Jong S Kim; Steven Warach
Journal:  Neurology       Date:  2015-12-18       Impact factor: 9.910

4.  Fitness and Mobility Exercise (FAME) Program for stroke.

Authors:  Janice J Eng
Journal:  Top Geriatr Rehabil       Date:  2010

Review 5.  Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study.

Authors:  William B Kannel; Philip A Wolf
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

Review 6.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 7.  Long term cost-of-illness in stroke: an international review.

Authors:  Krista A Payne; Krista F Huybrechts; J Jaime Caro; Traci J Craig Green; Wendy S Klittich
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 8.  Risk factors in stroke.

Authors:  P Mustacchi
Journal:  West J Med       Date:  1985-08

9.  Bayesian regression model for recurrent event data with event-varying covariate effects and event effect.

Authors:  Li-An Lin; Sheng Luo; Barry R Davis
Journal:  J Appl Stat       Date:  2017-08-26       Impact factor: 1.404

Review 10.  Task-oriented treadmill exercise training in chronic hemiparetic stroke.

Authors:  Frederick M Ivey; Charlene E Hafer-Macko; Richard F Macko
Journal:  J Rehabil Res Dev       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.